STATCenter·
STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better
Biotech executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price moves.
Read at STAT →
Health · 1 sources covering this
STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better
Biotech executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price moves.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/5359af69109d57a6826b769fd5a7a15d5a82ee7b" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better"></iframe>
